KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Goodwill & Intangibles: 2009-2025

Historic Goodwill & Intangibles for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Sep 2025 value amounting to $429.3 million.

  • Biomarin Pharmaceutical's Goodwill & Intangibles fell 6.08% to $429.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.3 million, marking a year-over-year decrease of 6.08%. This contributed to the annual value of $451.5 million for FY2024, which is 8.03% down from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Goodwill & Intangibles stood at $429.3 million for Q3 2025, which was down 1.49% from $435.8 million recorded in Q2 2025.
  • Biomarin Pharmaceutical's 5-year Goodwill & Intangibles high stood at $602.1 million for Q1 2021, and its period low was $429.3 million during Q3 2025.
  • Its 3-year average for Goodwill & Intangibles is $470.3 million, with a median of $461.7 million in 2024.
  • Data for Biomarin Pharmaceutical's Goodwill & Intangibles shows a maximum YoY fell of 10.44% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Goodwill & Intangibles stood at $584.9 million in 2021, then dropped by 8.56% to $534.8 million in 2022, then declined by 8.20% to $490.9 million in 2023, then declined by 8.03% to $451.5 million in 2024, then decreased by 6.08% to $429.3 million in 2025.
  • Its Goodwill & Intangibles stands at $429.3 million for Q3 2025, versus $435.8 million for Q2 2025 and $443.5 million for Q1 2025.